To determine the prognostic relevance of ZNF154 promoter hypermethylation, we analyzed the methylation ratios in the tumor tissues from 78 ESCC patients, of which 42 patients had been regularly followed-up. The gene discussed is ZNF154; the disease is neoplasm.